The U.S. Food and Drug Administration Tuesday authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.
It is clear that we are not out of the woods yet, and extending the PHE is critical to ensure states and health care providers have the tools and resources necessary to respond to this ongoing, global crisis.